Biodexa Pharmaceuticals Bolsa (NASDAQ: BDRX)

Últimas noticias sobre Biodexa Pharmaceuticals (NASDAQ:BDRX) Bolsa

Biodexa Pharmaceuticals

Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals PLC

BOMBARDIER 6.25% PFD A by Bombardier Inc.

Bombardier Inc

News

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

Faraday Future Calls U.S. Tariff Policy A 'Structural Opportunity' For Growth And Innovation In Domestic EV Market

Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) will release earnings results for the first quarter, after the <a href="https://www.benzinga.com/quote/LEVI/earnings">closing bell on Monday, April 7</a>.
Analysts expect the company to report quarterly earnings at 28 cents per share, up from 26 cents per share in the year-ago period. Levi Strauss projects to report quarterly revenue at $1.54 billion, compared to $1.56 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 29, Levi Strauss reported quarterly earnings of 50 cents per share which beat the analyst consensus estimate of 48 cents per share. The company reported quarterly sales of $1.840 billion which beat the analyst consensus estimate of $1.728 billion.
Levi Strauss shares tumbled 13.7% to close at $14.44 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/GBX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>UBS analyst Jay Sole maintained a Buy rating and cut the price target from $26 to $25 on Feb. 3, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Morgan Stanley analyst Alex Straton maintained an Equal-Weight rating and cut the price target from $18 to $17 on Jan. 30, 2025. This analyst has an accuracy rate of 63%.</li>
<li>Wells Fargo analyst Ike Boruchow maintained an Equal-Weight rating and slashed the price target from $20 to $17 on Jan. 30, 2025. This analyst has an accuracy rate of 70%.</li>
<li>JP Morgan analyst Matthew Boss maintained a Neutral rating and cut the price target from $21 to $19 on Jan. 24, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Citigroup analyst Paul Lejuez maintained a Neutral rating and lowered the price target from $21 to $19 on Jan. 17, 2025. This analyst has an accuracy rate of 64%.</li>
</ul>
Considering buying LEVI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="594" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04030323/image-39-1024x594.png" alt="" class="wp-image-856935" style="width:546px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04030323/image-39-1024x594.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04030323/image-39-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04030323/image-39-768x446.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04030323/image-39.png 1137w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44626468/top-3-risk-off-stocks-that-are-ticking-portfolio-bombs">Top 3 Risk Off Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Earnings

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

LEVI

Top Wall Street Forecasters Revamp Levi Strauss Price Expectations Ahead Of Q1 Earnings

With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects American Shared Hospital Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMS#NYSE">AMS</a>) to report quarterly earnings at 1 cent per share on revenue of $7.70 million before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. American Shared Hospital Services shares rose 0.3% to $2.97 in after-hours trading.</li>
<li>Guess? Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GES#NYSE">GES</a>) reported upbeat results for its fourth quarter and named Alberto Toni as CFO. The company said it sees FY26 revenue to increase 3.9% &#8211; 6.2% in US Dollars and adjusted EPS of $1.32 &#8211; $1.76. Guess shares fell 2.4% to $9.80 in the after-hours trading session.</li>
<li>NeuroOne Medical Technologies Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMTC#NASDAQ">NMTC</a>) disclosed a common stock public offering. NeuroOne Medical shares dipped 36.1% to $0.5499 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Simulations Plus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLP#NASDAQ">SLP</a>) posted stronger-than-expected results for its second quarter and issued upbeat FY25 earnings forecast. Simulations Plus shares gained 2.5% to $24.41 in the after-hours trading session.</li>
<li>Sangamo Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) announced a new agreement with pharmaceutical giant Eli Lilly And Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), granting the company a worldwide exclusive license to leverage the company's novel proprietary neurotropic adeno-associated virus (AAV) capsid, STAC-BBB. Sangamo Therapeutics shares jumped 47.7% to $0.9193 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44626468/top-3-risk-off-stocks-that-are-ticking-portfolio-bombs">Top 3 Risk Off Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

NMTC

SGMO

Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday

<ul>
<li>CenterPoint proposal to remove emergency temporary generation costs would lower monthly bills immediately and by as much as $2 per month by 2027</li>
<li>&nbsp;15 generation units would be sent to San Antonio area by Summer 2025 to help meet Texas' current and future energy needs</li>
</ul>

DVAX

Reported Earlier, CenterPoint Energy Moves To Reduce Electric Bills By Up To $2 Monthly By 2027

President Donald Trump's <a href="https://in.benzinga.com/news/global/25/04/44631606/trumps-tariff-exemptions-include-semiconductors-pharmaceuticals-oil-and-more">new reciprocal tariffs</a> could undermine the billion-dollar AI infrastructure projects being spearheaded by leading tech companies, analysts warn.
What Happened: On Thursday, analysts highlighted the negative impact of the Trump administration's tariffs on technology equipment, which were levied at 34% on China, 32% on Taiwan, and 25% on South Korea, while also imposing a 10% baseline tariff on all imports to the U.S., reported Reuters.
The tariffs threaten to raise the costs of essential hardware used in artificial intelligence infrastructure, such as data centers, servers, and chips.
See Also: <a href="https://www.benzinga.com/markets/25/04/44640656/apple-making-iphones-in-america-a-fantasy-that-sounds-great-behind-the-microphones-says-top-analyst-dan-ives">Apple Making iPhones In America A Fantasy That Sounds Great &#8216;Behind The Microphones,&#8217; Says Top Analyst Dan Ives</a>
&#8220;Capital expenditure by tech giants will get reshuffled,&#8221; said Abhishek Singh, partner at Everest Group. &#8220;Expect major players in AI infrastructure and consumer tech to reallocate short-term spending away from expansion and toward procurement hedging or sourcing shifts.&#8221;
The tariffs are expected to increase the cost of <a href="https://www.benzinga.com/markets/25/02/43908921/microsoft-pulls-plug-on-ai-data-center-leases-says-analyst-oversupply-situation-likely">building data centers</a> in the U.S., potentially delaying large-scale AI projects.
D.A. Davidson analyst Gil Luria pointed out that companies like Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) have already begun to scale back their data center investments due to financial uncertainty.
&#8220;Microsoft has already started articulating a more balanced, cautious approach to their data center build-out,&#8221; Luria noted.
The most high-profile project affected is the $500 billion Stargate venture between Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), SoftBank Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>), and OpenAI, aimed at building 20 data centers across the U.S.
&#8220;Stargate was already unlikely to get to that scale even before these things happened. Given the shock to the economy that these tariffs represent, it is highly unlikely that such a risky endeavor will be able to raise anywhere near that number in terms of debt financings,&#8221; stated Luria.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: President Trump&#8217;s sweeping new trade tariffs jolted global markets on Thursday, sparking a dramatic sell-off reminiscent of the pandemic-era crashes.
Wall Street witnessed a <a href="https://in.benzinga.com/government/regulations/25/04/44631916/wall-street-wipes-out-2-trillion-apple-eyes-worst-day-since-covid-19-pandemic-oil-plummets-whats-driving-markets-thursday">staggering $2 trillion wiped</a> from market value, with the 10 largest U.S. companies alone accounting for $1 trillion of those losses.
Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) plunged 9.25%, Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) fell 7.81%, Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) dropped 8.98%, and Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) slid 8.9%.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) declined 5.47%, while Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) lost 8.96%. Alphabet Inc.'s Class A shares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) dipped 4.02%, and Class C shares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) were down 3.92%, according to <a href="http://pro.benzinga.com/">data from Benzinga Pro</a>.
Photo Courtesy: Jack_the_sparow on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/43373775/tim-cook-praises-chinas-deepseek-for-driving-efficiency-stresses-apples-prudent-and-deliberate-approach-toward-capital-expenditure" target="_blank" rel="noreferrer noopener">Tim Cook Praises China's DeepSeek For Driving Efficiency, Stresses Apple's ‘Prudent And Deliberate' Approach Toward Capital Expenditure</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tech

Media

AAPL

AMZN

GOOG

GOOGL

MSFT

NVDA

ORCL

SFTBF

SFTBY

TSLA

Trump's Reciprocal Tariffs Threaten To Derail Big Tech's Billion-Dollar AI Infrastructure Plans, Analyst Singles Out This OpenAI-Linked Project As Likely To Get Hit

As U.S. markets witnessed a blood bath on Thursday, owing to the imposition of tariffs by the Trump administration and growing recessionary fears, a handful of stocks thoroughly defied the odds, rallying amid the broader chaos.
What Happened: The Dow, S&amp;P 500, and the Nasdaq, all witnessed their steepest declines since the pandemic, with most U.S. stocks ending the day in the red.
See More: <a href="https://www.benzinga.com/25/04/44641009/ford-launches-from-america-for-america-discount-program-as-tariffs-threaten-vehicle-price-surge">Ford Launches &#8216;From America, For America&#8217; Discount Program As Tariffs Threaten Vehicle Price Surge</a>
Yet, a few outliers such as the Goodyear Tire &amp; Rubber Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>), Lamb Weston Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>), First Solar Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>), Dollar General Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>), and the American Water Works Company Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWK#NYSE">AWK</a>) have managed to win the day.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td class="has-text-align-center" data-align="center">Company</td>
<td class="has-text-align-center" data-align="center">Yesterday</td>
<td class="has-text-align-center" data-align="center">Year-to-Date</td>
<td class="has-text-align-center" data-align="center">52-Week Range</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Goodyear Tire &amp; Rubber Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>)</td>
<td class="has-text-align-center" data-align="center">+11.73%</td>
<td class="has-text-align-center" data-align="center">+16.46%</td>
<td class="has-text-align-center" data-align="center">$7.27 &#8211; $13.78</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Lamb Weston Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>)</td>
<td class="has-text-align-center" data-align="center">+10.01%</td>
<td class="has-text-align-center" data-align="center">-9.80%</td>
<td class="has-text-align-center" data-align="center">$47.90 &#8211; $89.51</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">First Solar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>)</td>
<td class="has-text-align-center" data-align="center">+4.94%</td>
<td class="has-text-align-center" data-align="center">-26.94%</td>
<td class="has-text-align-center" data-align="center">$120.60 &#8211; $306.77</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Dollar General Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>)</td>
<td class="has-text-align-center" data-align="center">+4.66%</td>
<td class="has-text-align-center" data-align="center">+24.83%</td>
<td class="has-text-align-center" data-align="center">$66.43 &#8211; $164.12</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">American Water Works Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWK#NYSE">AWK</a>)</td>
<td class="has-text-align-center" data-align="center">+3.95%</td>
<td class="has-text-align-center" data-align="center">+22.69%</td>
<td class="has-text-align-center" data-align="center">$66.43 &#8211; $164.12</td>
</tr>
</tbody>
</table>
</figure>
<h3 class="wp-block-heading">1) Goodyear Tire &amp; Rubber Co.</h3>
Goodyear Tire &amp; Rubber was a bright spot on Thursday, rallying nearly 12% amidst all the chaos, making it the day&#8217;s top gainer.
Edison Yu, an analyst at Deutsche Bank, believes Goodyear to be <a href="https://in.benzinga.com/25/04/44614534/5-car-stocks-that-will-benefit-from-trumps-liberation-day">a &#8216;relative winner&#8217; of Trump&#8217;s trade wars</a>, as most of its U.S. demand is filled with domestic manufacturing. As a result, it is less exposed to tariffs on imports, relative to peers in this industry.
Yu further adds that Goodyear&#8217;s focus on replacement tires, which make up 85% of its revenue, is set to benefit from the auto tariffs, as consumers will stick with their vehicles longer, leading to more tire changes. The stock has been upgraded to a &#8216;BUY&#8217; with a price target of $13, as <a href="https://www.investing.com/analysis/why-goodyear-tire-stock-is-a-relative-winner-amid-tariff-turmoil-200659060">reported</a> by Investing.com.
<h3 class="wp-block-heading">2) Lamb Weston Holdings Inc</h3>
Consumer staples were, in fact, only 1 of 11 sectors in the S&amp;P 500 to finish the day higher, as investors rushed to safe havens, and Lamb Weston Holdings was one of them, gaining 10%.
Analysts like Citi&#8217;s Filippo Falorni have long considered staples to be recession-proof and resilient in the face of uncertainty, telling the <a href="https://www.wsj.com/finance/stocks/consumer-staples-gain-on-rush-to-safety-after-tariffs-spark-market-rout-45d2582b">Wall Street Journal</a> that investors can expect &#8216;stable earnings and revenue even in a tough environment.&#8217;
<h3 class="wp-block-heading">3) First Solar Inc</h3>
First Solar rallied nearly 5% on Thursday, being an American-made solar panel company, which allows it to dodge tariffs that apply to its competitors.
Chinese-made solar panels, which were the company&#8217;s biggest competitors, are now at a considerable disadvantage. <a href="https://www.renewableenergyworld.com/energy-business/why-is-first-solar-stock-soaring-while-much-of-the-market-sags/">Renewable Energy World</a> reports that investors in solar energy will seek to avoid the massive 54% tax on Chinese panels, while also earning the tax credits from the Inflation Reduction Act, giving a strong impetus to First Solar.
<h3 class="wp-block-heading">4) Dollar General</h3>
Investors likely pursued Dollar General as another recession-proof stock, being a major discount retailer with nearly 20,000 stores, leading to a 4% spike on Thursday, and an 18% rally since the beginning of March. 
However, this theory doesn&#8217;t hold up too well, as Billy Duberstein <a href="https://www.fool.com/investing/2025/04/03/dollar-general-rallied-18-in-march-market-crash/">writes</a> for the Motley Fool, that during the post-pandemic inflationary period, Dollar General was hit with an expensive combination of inflation hitting its low-income customers&#8217; purchasing power, along with a rise in theft. 
<h3 class="wp-block-heading">5) American Water Works </h3>
A public utility that provides water and wastewater solutions, American Water Works is well insulated from global trade, tariffs, and geopolitics, making it the perfect safe haven stock.
People are unlikely to stop using water during a recession, and add to this, the stock offers an annualized yield of 2%, making it a great pick for those looking to overcome the tariff upheaval. 
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="168" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04021828/Screenshot-2025-04-04-at-11.46.51-AM-1024x168.png" alt="" class="wp-image-856846" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04021828/Screenshot-2025-04-04-at-11.46.51-AM-1024x168.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04021828/Screenshot-2025-04-04-at-11.46.51-AM-300x49.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04021828/Screenshot-2025-04-04-at-11.46.51-AM-768x126.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/04021828/Screenshot-2025-04-04-at-11.46.51-AM.png 1412w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
According to Benzinga Edge Stock Rankings, Dollar General paints a pretty mixed picture as of now, but what about the others on this list? <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Sign up to Benzinga Edge</a> today and find out.
Image via Shutterstock
Read More: <a href="https://www.benzinga.com/markets/25/04/44640798/trump-ends-de-minimis-exemptions-shopify-bigcommerce-and-lightspeed-face-new-headwinds">Trump Ends De Minimis Exemptions: Shopify, BigCommerce And Lightspeed Face New Headwinds</a>

Government

FSLR

As Trump Tariffs Rippled Through The Markets, Goodyear Tire And These Stocks Defied The Downturn — Here's Why

LGI Homes, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGIH#NASDAQ">LGIH</a>) today announced it closed 426 homes in March 2025. The Company closed 996 homes during the first quarter of 2025.
As of March 31, 2025, the Company had 146 active selling communities.

LGIH

Reported Earlier, LGI Homes Closed 426 Homes In March And A Total Of 996 Homes In Q1. As Of March 31, 2025, It Had 146 Active Selling Communities

Oral Plenary Presentation on Tuesday, April 8 Features Phase 3 Data for ANX005, the First Potential Targeted Therapy for GBS, Showing Rapid and Durable Benefit Across Clinical Measures and Time Points
Educational Symposium Focuses on Advancing GBS Care and Role of Classical Complement Pathway
New Disease Education Campaign "Move GBS Forward" Draws Attention to Life-altering Physical and Mental Impact of GBS

ANNX

Reported Earlier, Annexon Spotlights First-in-Class ANX005 Phase 3 Results For GBS And Launches 'Move GBS Forward' Initiative At AAN

MESO

Reported Earlier, Mesoblast Confirms U.S. Origin Status For Allogeneic Cell Therapies, Exempting Products From New Tariffs

<ul>
<li>Toyota Introduces&nbsp;GR Supra MkV Final Edition at Grand Prix of Long Beach</li>
<li>MkV Final Edition Features Optimized Tuning, Improved Braking and Chassis and Suspension Updates</li>
<li>3.0 and 3.0 Premium Grades Available</li>
<li>All Grades Offer 382 Horsepower with 368 lb-ft. of Torque</li>
</ul>

Reported Earlier, Toyota Says Goodbye To the MkV Era With GR Supra Final Edition

Reported Earlier, Western Union Activates Emergency Relief Measures With No-Fee Transfers To Myanmar Via App and Website

GORO

Reported Earlier, Gold Resource Reports High-Grade 2024 Drill Results, Unveiling Promising New Vein Systems At Don David Gold Mine

Reported Earlier, Brookfield Infrastructure To Acquire Colonial Enterprises In $9B Deal, Securing U.S.'s Largest Refined Products Pipeline

<ul>
<li>Alcon welcomes its shareholders to its third in-person AGM</li>
<li>Alcon Board of Directors proposes to elect Deborah Di Sanzo as a new Board member</li>
<li>Proposed dividend of CHF 0.28 cash per share</li>
</ul>

Alcon Proposes CHF 0.28 Cash Dividend Ahead Of 2025 AGM And Nomination Of New Tech-Focused Board Member

Macro Economic Events

Econ #s

Economics

Germany Factory Orders (MoM) For February 0.0% Vs. 3.4% Est.; -5.5.% (Revised) Prior

BBJP

WisdomTree Trust Japan Total Dividend Fund

Reported Earlier, Japan Household Spending (YoY) For February -0.5% Vs. -0.9% Est.; 0.8% Prior

Reported Earlier, Japan Household Spending (MoM) For February 3.5% Vs. 0.5% Est.; -4.5% Prior

On Thursday, President Donald Trump confirmed that the U.S. is <a href="https://in.benzinga.com/general/social-media/25/02/43511395/trump-pushes-for-tiktok-deal-china-could-oblige-if-it-werent-for-those-tariffs-heres-what-we-know">nearing a deal</a> to spare TikTok from a potential ban, with ongoing discussions involving multiple investors and a possible tariff agreement with China.
What Happened: During remarks aboard Air Force One, Trump said, &#8220;We're very close to a deal with a very good group of people,&#8221; <a href="https://www.bloomberg.com/news/articles/2025-04-03/trump-says-tiktok-deal-within-reach-involves-multiple-investors?srnd=phx-technology">reported</a> Bloomberg.
<a href="https://in.benzinga.com/25/03/44506732/donald-trump-says-he-may-cut-tariffs-on-china-to-seal-tiktok-deal-bytedance-has-until-april-5-to-sell-or-face-us-ban">Trump also reiterated</a> that he would be willing to offer tariff relief as part of the negotiation process with China to help secure approval for the eventual sale of TikTok.
See Also:&nbsp;<a href="https://www.benzinga.com/tech/25/03/44506409/steve-jobs-warned-34-years-ago-about-america-being-hollowed-out-by-foreign-manufacturing-a-concern-trump-now-echoes" target="_blank" rel="noreferrer noopener">Steve Jobs Warned 34 Years Ago About America Being ‘Hollowed Out' By Foreign Manufacturing — A Concern Trump Now Echoes</a>
&#8220;You have a situation with TikTok where China will probably say, we'll approve a deal but will you do something on the tariff? The tariffs give us great power to negotiate. They always have,&#8221; he stated.
However, he admitted that he had &#8220;no knowledge&#8221; of whether Chinese authorities would approve the approach.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: TikTok, the Chinese-owned social media app owned by ByteDance, has faced increasing scrutiny over national security concerns related to data privacy and its algorithm.
The president's latest comments follow discussions with a consortium of U.S. investors, including Blackstone Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>), Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) and Andreessen Horowitz, looking to acquire the app.
Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) has also reportedly made a<a href="https://in.benzinga.com/news/25/04/44613084/amazon-makes-surprise-bid-for-tiktok-amid-us-ban-threat-report"> last-minute surprise bid</a> to buy the entire U.S. operation of TikTok.
Image via Shutterstock
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/03/44487688/signal-touts-gold-standard-encryption-as-trump-administration-leak-spotlight-intensifies-our-code-is-regularly-scrutinized" target="_blank" rel="noreferrer noopener">Signal Touts ‘Gold Standard' Encryption As Trump Administration Leak Spotlight Intensifies: ‘Our Code Is Regularly Scrutinized'</a></li>
</ul>

Trump Says US Near TikTok Deal, Reiterates Trade Relief Offer For China's Approval: 'Tariffs Give Us Great Power To Negotiate'

Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) announced Thursday it will extend employee pricing to all car shoppers, a move that coincides with the implementation of new 25% U.S. tariffs on <a href="https://www.benzinga.com/trading-ideas/movers/25/04/44632051/ford-stock-falls-as-auto-tariffs-take-effect-whats-going-on">imported vehicles and auto parts</a>.
What Happened: The &#8220;From America, For America&#8221; promotion allows consumers to purchase 2024-2025 Ford and Lincoln vehicles, including gas, electric and hybrid models, at prices typically reserved for company employees. The offer runs Apr. 3 through Jun 2, though it excludes Raptor models, 2025 Expedition and Navigator SUVs, and Super Duty trucks.
&#8220;We understand that these are uncertain times for many Americans,&#8221; Ford said in a <a href="https://www.cbsnews.com/news/ford-promo-employee-discount-trump-tariffs-car-prices/">statement</a> to CBS News. &#8220;Whether it&#8217;s navigating the complexities of a changing economy or simply needing a reliable vehicle for your family, we want to help.&#8221;
The promotion launches as analysts warn of significant price increases for vehicles due to the tariffs. Wedbush Securities analyst Dan Ives described the situation as a &#8220;tariff torpedo&#8221; and &#8220;pure chaos&#8221; for the auto industry, estimating price hikes of $5,000 to $10,000 for typical vehicles, with luxury models potentially <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44630499/trump-auto-tariffs-could-up-car-prices-by-15k-analyst-calls-it-pure-chaos">seeing increases up to $15,000</a>. 
Ford has already benefited from consumers rushing to purchase vehicles ahead of expected price increases. The company reported a 5% rise in first-quarter sales, driven by a 19% surge in March.
See Also: <a href="https://www.benzinga.com/markets/equities/25/04/44640787/mark-cuban-warns-of-price-hikessays-buy-consumables-now-before-retailers-blame-tariffs">Mark Cuban Warns Of Price Hikes, Says &#8216;Buy Consumables Now,&#8217; Before Retailers Blame Tariffs</a>
Why It Matters: The impact of the tariffs is already rippling through the industry. Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) announced production pauses at plants in Canada and Mexico, with temporary layoffs affecting 900 workers in the Midwest and 4,500 employees at its Windsor Assembly Plant.
The auto tariffs are part of broader trade measures announced by President Donald Trump, which analysts say will likely <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44630499/trump-auto-tariffs-could-up-car-prices-by-15k-analyst-calls-it-pure-chaos">increase prices across various consumer goods</a>. Even U.S. manufacturers like Ford rely on 40-50% of parts sourced from abroad, making the concept of an all-American-made car what Ives calls &#8220;a fairy tale fictional narrative.&#8221;
Price Action: Ford stock closed at $9.54 on Wednesday, down 6.01% for the day. In after-hours trading, the stock rose 0.42% to $9.58. Year to date, Ford shares are down 1.14%.
According to Benzinga Edge Stock Rankings, Ford currently lacks medium- to long-term price momentum but benefits from a strong valuation and a positive short-term price trend. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Sign up to learn more</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/04/44632423/kevin-o-leary-says-by-33-you-should-have-100000-saved-somewhere-thats-the-age-when-its-really-time-to-start-getting-focused" target="_blank" rel="noreferrer noopener">Kevin O&#8217; Leary Says By 33, You Should Have $100,000 Saved ‘Somewhere&#8217; — ‘That&#8217;s the Age When it&#8217;s Really Time to Start Getting Focused</a>‘</li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

STLA

Ford Launches 'From America, For America' Discount Program As Tariffs Threaten Vehicle Price Surge

Miller Value Partners, led by Bill Miller IV, reduced its MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) holdings by 70% to 15,250 shares from 50,250 shares in the fourth quarter of 2024, according to a 13F-HR filed with the U.S. Securities and Exchange Commission on Feb. 14.
What Happened: With MicroStrategy&#8217;s stock declining 7.69% from $337.73 to $312.54 as of Apr. 2, the investment firm avoided potential losses of approximately $881,650 by selling 35,000 shares.
The firm had initially purchased 50,000 MSTR shares at $327.67 on Nov. 14, building an $8.47 million position. This investment yielded <a href="https://in.benzinga.com/markets/cryptocurrency/25/01/43295510/bill-miller-snapped-up-50k-microstrategy-shares-in-q3-was-it-a-smarter-play-than-bitcoin-etfs">considerably lower returns</a> compared to Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) ETFs in the third quarter.
See Also: <a href="https://www.benzinga.com/markets/equities/25/04/44620686/sp-500-nasdaq-futures-plunge-over-3-as-trumps-reciprocal-tariff-plan-hits-market-confidence">Trump&#8217;s &#8216;Reciprocal Tariff&#8217; Plan Hits Market Confidence As Dow Futures Drop Over 830 Points</a>
Why It Matters: This move follows a family legacy of Bitcoin investment. Bill Miller III, the founder&#8217;s father and renowned investor, made headlines for his <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40543953/despite-market-jitters-investor-bill-miller-stands-firm-on-bitcoin-an-insurance-policy-aga">early Bitcoin adoption in 2012</a>, purchasing the cryptocurrency at around $700.
The elder Miller, known for beating the S&amp;P 500 Index for 15 consecutive years at Legg Mason Value Trust, has been a vocal advocate for Bitcoin as a hedge against financial instability.
&#8220;Bitcoin is an insurance policy against financial catastrophe, against inflation,&#8221; the senior <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40543953/despite-market-jitters-investor-bill-miller-stands-firm-on-bitcoin-an-insurance-policy-aga">Miller said in August</a>, recommending investors allocate 1% of their liquid assets to the cryptocurrency.
Miller Value Partners currently manages approximately $290 million in assets through its Miller Income mutual fund and two ETFs, focusing on value investment strategies <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40543953/despite-market-jitters-investor-bill-miller-stands-firm-on-bitcoin-an-insurance-policy-aga">across various asset classes</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44620222/bitcoin-ethereum-dogecoin-give-up-early-gains-on-trumps-tariff-liberation-day-analyst-flags-levels-where-buying-btc-could-result-in-substantial-gains">Bitcoin, Ethereum, Dogecoin Crash On Trump&#8217;s Tariff &#8216;Liberation Day&#8217; — Analyst Says Buying BTC Between These Levels Could Lead To &#8216;Substantial Gains&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

IBIT

MSTR

Bill Miller's Firm Slashed MicroStrategy Stake By 70%: The Move That Dodged A Costly Hit

Press Releases

Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer

Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis

Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status

Biodexa Pharmaceuticals PLC to Present at the Emerging Growth Conference on February 19, 2025

Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register Now

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

Legal

Biodexa Announces Allowance of U.S. Patent Covering  Oral Rapamycin Nanoparticle Preparations ("eRapa") and Use

Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP

Health Care

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP

With Fast Track Designation in Hand, a Successful Protocol Discussion with FDA, and CROs in Place, Biodexa is on Track to Initiate its Funded Phase 3 Trial in FAP Next Quarter

AEMD

ANPCY

ASPI

ATWT

BDRX

BENF

BIXT

BNRG

BOSC

CSE:HG

ELRRF

GOSS

GOVX

HDRSF

HGRAF

IMRN

IPWR

JAGX

LGVN

PBEGF

RGBP

SIGY

SWKH

TSX:CNL

TSX:ELO

TSX:TXP

TSXV:HI

TSXV:WRLG

UCAR

USEG

WRLGF

XXII

Apollomics

Aptevo Therapeutics

Bone Biologics

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Entero Therapeutics

GRI Bio

Onconetix

Polyrizon

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Revelation Biosciences, Inc. - Common Stock

Revelation Biosciences

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Scorpius Holdings

Salarius Pharmaceuticals, Inc. - Common Stock

Salarius Pharmaceuticals

Vincerx Pharma

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

ZyVersa Therapeutics, Inc. - Common Stock

ZyVersa Therapeutics

Ladenburg Thalmann

Screenshot 2025-03-18 at 8.36.36 PM

Biotech

General

Fast Track Designation Secured, Successful Protocol Discussion With FDA And CROs Confirmed, Biodexa On Track To Initiate Funded Phase 3 FAP Trial Next Quarter

Untitled design - 2025-02-11T232646.924

Following Positive Phase 2 Results And Orphan Drug Designation, Biodexa&#39;s FAP Drug Receives FDA Fast Track Status

Image

Gaining Momentum, Biodexa Is Advancing Two Recent Acquisitions Through The Clinic

Untitled design - 2024-10-16T235234.675

Biodexa&#39;s MX-110 Continues To Show Promise In Recurrent Glioblastoma (rGBM), The Deadliest Brain Cancer

Screenshot 2024-07-10 at 9.15.35 PM

Biodexa Announces Additional Positive Results Of Phase 2 Trial Of eRapa In Treatment Of Precancerous Polyps In The GI Tract – Now 12-Month Data

Screenshot 2024-06-03 at 5.21.04 PM

Promising Phase 2 Results For Biodexa&#39;s eRapa™ Indicates Hope For FAP Patients Who Otherwise Have A 100% Lifetime Risk Of Colorectal Cancer

Screenshot 2024-05-08 at 7.48.00 PM

Biodexa Looks To Prevent Or Delay The Worst Outcomes For Adolescents And Young Adults With Devastating Precancerous Condition

Untitled design - 2024-03-28T172702.605

Biodexa&#39;s MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers

Redington 2_29

PowerShares Dynamic Financial Sector Portfolio

Biodexa Takes Aim At Type 1 Diabetes With Innovative Drug Candidate Tolimidone

Comments

Biodexa Pharmaceuticals

Noticias

Últimas noticias sobre Biodexa Pharmaceuticals (NASDAQ:BDRX) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL